Patients With Her2positive Advanced Breast Cancer clinical trials
Explore recruiting patients with her2positive advanced breast cancer clinical trials.
Also recruiting in Europe
Patients With Her2positive Advanced Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.
Patients With Her2positive Advanced Breast Cancer trials by city
Patients With Her2positive Advanced Breast Cancer in Toronto
Patients With Her2positive Advanced Breast Cancer in Vancouver
Patients With Her2positive Advanced Breast Cancer in Montreal
Patients With Her2positive Advanced Breast Cancer in Calgary
Patients With Her2positive Advanced Breast Cancer in Edmonton
Patients With Her2positive Advanced Breast Cancer in Ottawa
Patients With Her2positive Advanced Breast Cancer in Winnipeg
Patients With Her2positive Advanced Breast Cancer in Quebec City
Patients With Her2positive Advanced Breast Cancer in Hamilton
Patients With Her2positive Advanced Breast Cancer in Kitchener
Patients With Her2positive Advanced Breast Cancer in London
Patients With Her2positive Advanced Breast Cancer in Halifax
Patients With Her2positive Advanced Breast Cancer in New York
Patients With Her2positive Advanced Breast Cancer in Los Angeles
Patients With Her2positive Advanced Breast Cancer in Chicago
Patients With Her2positive Advanced Breast Cancer in Houston
Other conditions
Obesity
Type 2 diabetes
Type 1 diabetes
Prediabetes
Weight loss
Metabolic syndrome
High cholesterol
High triglycerides
High blood pressure
PCOS
Hypothyroidism
Thyroid disease
Gout
Fatty liver disease (NAFLD/NASH)
Heart failure
Coronary artery disease
Atrial fibrillation
Stroke
Stroke recovery
Peripheral artery disease
Pulmonary hypertension
Deep vein thrombosis
Chronic kidney disease
Diabetic kidney disease